not-yet-known not-yet-known not-yet-known unknown Therapies to prevent progression of COVID-19, including Ivermectin, Doxycycline, Vitamin C, Vitamin D, and Zinc with or without Famotidine: a randomised controlled double-blind multi-centre outpatient cohort study

20250 citationsJournal Articlegold Open Access

Authors

Liss Dyah Dewi A · The University of Queensland

Karin Ried · National Institute of Integrative Medicine

Bruce Wauchope · Bedford VA Research Corporation

Lisa Murnane · National Institute of Integrative Medicine

Elizabeth Harradine · National Institute of Integrative Medicine

Josie Seman · Universidade Estadual de Maringá

Abstract

Objectives A randomised controlled multi-centre cohort study was undertaken to assess a combination of repurposed drugs and supplements in the early therapy of acute non-hospitalised COVID-19 illness. Methods Participants over 40-years-old and positiv

Topics & Keywords

Complementary and Alternative Medicine Studies Vitamin D Research Studies Vitamin C and Antioxidants Research

Publication Details

DOI: 10.22541/au.176072414.48837718/v1

Field-Weighted Citation Impact: 0.00

Command Palette

not-yet-known not-yet-known not-yet-known unknown Therapies to prevent progression of COVID-19, including Ivermectin, Doxycycline, Vitamin C, Vitamin D, and Zinc with or without Famotidine: a randomised controlled double-blind multi-centre outpatient cohort study

Authors

Abstract

Topics & Keywords

Publication Details